T cell immunoglobulin domain and mucin domain-3 as an emerging target for immunotherapy in cancer management

T cell immunoglobulin domain and mucin domain-3 as an emerging target for immunotherapy in cancer management

Akihiro Yoneda, Masahisa Jinushi Research Center for Infection-associated Cancer, Institute for Genetic Medicine, Hokkaido University, Sapporo, Japan Abstract: Cancer-induced immunosuppression significantly impacts tumors, rendering them the ability to acquire aggressive and treatment-resistant phe...

Full description

Bibliographic Details
Main Authors: Yoneda A, Jinushi M
Format: Article
Language:English
Published: Dove Medical Press 2013-11-01
Series:ImmunoTargets and Therapy
Subjects:
TIM-3
tumor immunoevasion
cancer immunotherapy
antibody
Online Access:https://www.dovepress.com/t-cell-immunoglobulin-domain-and-mucin-domain-3-as-an-emerging-target--peer-reviewed-article-ITT

Internet

https://www.dovepress.com/t-cell-immunoglobulin-domain-and-mucin-domain-3-as-an-emerging-target--peer-reviewed-article-ITT

Similar Items